Sammenlign metoder
Gennemgå dine valgte metoder side om side; rækker, der afviger, er fremhævet.
| Maskinlærings-augmenteret instrumentvariabel-analyse (ML-IV)× | Instrumentalvariabel (IV) Metoden til Kausal Inferens× | |
|---|---|---|
| Fagområde≠ | Kausal inferens | Sundhedsøkonomi |
| Familie≠ | Regression model | Process / pipeline |
| Oprindelsesår≠ | 2012-2018 | 1990s (modern applications) |
| Ophavsperson≠ | Belloni, Chernozhukov & Hansen; Chernozhukov et al. | Angrist & Pischke (applied econometrics); rooted in econometric theory |
| Type≠ | Causal inference / semi-parametric estimation | Method |
| Oprindelig kilde≠ | Chernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. The Econometrics Journal, 21(1), C1-C68. DOI ↗ | Angrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗ |
| Aliasser | ML-IV, MLIV, Double/Debiased ML with IV, DML-IV | IV, two-stage least squares, TSLS, causal estimation |
| Relaterede≠ | 4 | 3 |
| Resumé≠ | Machine learning-augmented instrumental variables combines the causal identification power of classical IV with modern high-dimensional machine learning — using methods such as LASSO, random forests, or neural networks to select valid instruments and model nuisance functions, thereby improving first-stage fit and enabling valid inference even when the number of potential instruments or controls is large relative to the sample size. | Instrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes. |
| ScholarGateDatasæt ↗ |
|
|